PS(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

QPQIUVRFRMEHGI-KTIJQTJVSA-N

InChI Key

QPQIUVRFRMEHGI-KTIJQTJVSA-N

IUPAC name

(2S)-2-amino-3-[[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

Preferred name

PS(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:188070

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Wild_type_vs_hfq
• Control_12h_vs_Toxocara canis_12h
• Normal_vs_Neural_Tube_Defect
• G1_Ctrl_vs_G2_Ab
• BSA_Control_vs_AA